Status:
UNKNOWN
Angiogenesis Markers in Primiparas Versus Multiparas: Relevance to Preeclampsia Incidence
Lead Sponsor:
Hadassah Medical Organization
Collaborating Sponsors:
Beth Israel Deaconess Medical Center
Conditions:
Pre-Eclampsia
Eligibility:
FEMALE
Brief Summary
The reason for having a higher incidence of preeclampsia in primiparas may involve angiogenesis imbalance in these patients.
Detailed Description
Primiparity is one of the main risk factors for having preeclampsia during pregnancy. Recently, sFlt-1, soluble FMS-like tyrosine kinase-1, has been shown to be a major molecule involved in the pathog...
Eligibility Criteria
Inclusion
- Every delivery
Exclusion
- Preeclampsia or pregnancy induced hypertension
Key Trial Info
Start Date :
November 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00262093
Start Date
November 1 2005
Last Update
March 20 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization
Jerusalem, Israel, 91240